Corporate buybacks surged in April, led by Apple, Alphabet, and Wells Fargo, signaling confidence and boosting stock prices. Tech and consumer companies also joining the buyback binge.
Analysts, including those from Wells Fargo, UBS, Raymond James, and Craig-Hallum, slashed their price targets and expressed concerns over the company's growth and execution challenges.
The drugmaker’s first-quarter revenue of $41.1 million came in well below the consensus estimate of $56.7 million, attributed to changes in AbbVie’s gross-to-net rebate reserves.
(BPT) - The number of business-savvy mothers blazing the trail as entrepreneurs is at a record high. "Mompreneurs" are transforming the business landscape, not just for themselves, but also for future generations. According to Wells Fargo, growth in the number of female business owners has outpaced the market in recent years, with women-owned companies representing 39% of all businesses.
Wells Fargo just approved a $40 billion buyback program for its own stock, giving investors some signs of potential rebounds and rallies in the future.
Regulus Therapeutics shares surged after Novartis announced a $1.7 billion acquisition, but analysts downgraded the stock citing limited upside. Retail sentiment remained bullish, with speculation of a higher bid or FDA-driven gains.
